Aarti Pharmalabs Ltd (AARTIPHARM) — Sustainability Report | 29 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Aarti Pharmalabs submitted its BRSR report to BSE and NSE on August 29, 2026, as required under SEBI regulations.
💡 Investor Takeaway
The BRSR filing reflects Aarti Pharmalabs' commitment to ESG transparency and sustainable operations, enhancing its appeal to responsible investors.

Aarti Pharmalabs Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26 to BSE and NSE on August 29, 2026, as mandated under SEBI Regulation 34(2)(f). The report details ESG disclosures across operations, including carbon footprint, water and waste management, employee welfare, governance, and stakeholder engagement. It highlights a Type 2 Moderate assurance on sustainability indicators, proactive CSR initiatives in aspirational districts, and compliance with environmental and human rights standards. The company emphasizes sustainable sourcing, renewable energy adoption, and zero liquid discharge. Governance includes Board-level oversight via the Risk Management Committee. No material changes from the previous period were disclosed, and no forward guidance was provided. The filing underscores transparency and commitment to responsible business practices.

📄 View Original Announcement (PDF)

About Aarti Pharmalabs Ltd (AARTIPHARM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹7,657.91 Cr P/E: 35.9 ROE: 10.7% ROCE: 14.1% Div Yield: 0.41%

View full AARTIPHARM stock details →

📡 Get AI alerts when AARTIPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AARTIPHARM — Free

📊 More AARTIPHARM filings

See all AARTIPHARM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AARTIPHARM files new disclosures

Track AARTIPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AARTIPHARM — Free

Free account · 2 AI queries/day